Last week’s significant research news included Germany’s BioNTech and US pharma major Bristol Myers Squibb releasing new data ...

Privately-held California, USA-based drug developer Ashvattha Therapeutics announced positive top-line end-of-study results ...

US biotech Dewpoint Therapeutics, a specialist in transforming condensate biology into medicine, has announced the closing of ...

FibroGen closed 8% higher Thursday after a settlement was announced in a case involving Kin-Hung Peony Yu, the company’s ...

The global economy is undergoing seismic shifts, shaped by changing demographics, climate pressures, supply chain upheavals, ...

Chicago-based private equity firm GTCR has agreed to acquire Czech generic drugmaker Zentiva from Advent International in a ...

Intercept Pharmaceuticals, a wholly-owned biopharmaceutical subsidiary of Italy’s privately-held Alfasigma, has announced its ...

Revolution Medicines (Nasdaq: RVMD) said Tuesday that it is advancing daraxonrasib into Phase III testing for pancreatic ...

Private equity firm GTCR has bought Czech Republic-based generics company Zentiva for a reported 4.1 billion euros ($4.8 ...

AbbVie (NYSE: ABBV) said in a regulatory filing that it has resolved all litigation with manufacturers seeking to market ...

Uni-Bio Science Group today revealed a strategic cooperation agreement with fellow Hong Kong-based Kexing Biopharm, a leading ...

California, USA-based clinical-stage biotech Maze Therapeutics closed up 54.8% at $24.80 yesterday, after it revealed it has ...